1. Alvino, H., Norman, R.J. and Matthews, C.D. (1995) Recombinant human follicle stimulating hormone (Gonal-F, Serono) compared to urinary follicle stimulating hormone (Metrodin) in IVF cycles: a randomised control study. Fertility Society of Australia/Australian Gynecological Endoscopy Society 1995 Annual Meeting (abstract FSA 46).
2. Andersen, A.N., Loft, A., Leerentveld, R. et al. (1998) A prospective trial comparing Puregon 150 IU and Metrodin-HP 225 IU as a fixed-dose regimen in IVF treatment. Hum . Reprod., 13, (Abstract book 1),185 (abstract P-112).
3. Bergh, C., Howles, C.M., Borg, K. et al. (1997) Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum. Reprod., 10, 2133–2139.
4. Breslow, N.E. and Day, N.E. (1980) Statistical Methods in Cancer Research, Vol I. Analysis of Data from Retrospective Studies of Disease. AIRC Scientific Publications, Lyon.
5. Chappel, S.C. (1995) Heterogeneity of follicle stimulating hormone: control and physiological function. Hum. Reprod. Update, 1, 479–487.